Literature DB >> 9130942

Does central obesity reflect "Cushing's disease of the omentum"?

I J Bujalska1, S Kumar, P M Stewart.   

Abstract

BACKGROUND: Central obesity results in a cluster of metabolic abnormalities contributing to premature death. Glucocorticoids regulate adipose-tissue differentiation, function, and distribution, and in excess, cause central obesity. Glucocorticoid hormone action is, in part, controlled by two isoforms of the enzyme 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) which interconverts hormonally active cortisol to inactive cortisone. We studied cortisol metabolism within different adipose tissue depots.
METHODS: We analysed expression and activity of the two isoforms (1 and 2) of 11 beta-HSD in cultured omental and subcutaneous adipose stromal cells from 16 patients undergoing elective abdominal surgery.
FINDINGS: Only the type 1 isoform (11 beta-HSD1) was expressed in adipose stromal cells. The predominant activity was oxo-reductase (conversion of cortisone to cortisol greater than cortisol to cortisone) and was higher in omental than subcutaneous fat (cortisone to cortisol, median 57.6 pmol mg-1 h-1 [95% CI 25.8-112.9] vs 0 pmol mg-1 h-1 [0-0.6], p < 0.001). 11 beta-HSD1 oxo-reductase activity was further increased (127.5 pmol mg-1 h-1 [82.1-209], p < 0.05) when omental adipose stromal cells were treated with cortisol and insulin.
INTERPRETATION: Adipose stromal cells from omental fat, but not subcutaneous fat, can generate active cortisol from inactive cortisone through the expression of 11 beta-HSD1. The expression of this enzyme is increased further after exposure to cortisol and insulin. In vivo, such a mechanism would ensure a constant exposure of glucocorticoid specifically to omental adipose tissue, suggesting that central obesity may reflect "Cushing's disease of the omentum".

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130942     DOI: 10.1016/S0140-6736(96)11222-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  133 in total

Review 1.  The adrenal and the metabolic syndrome.

Authors:  M S Golub
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 3.  Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?

Authors:  P G Kopelman
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

4.  More on adrenal activity in the metabolic syndrome.

Authors:  Michael L Tuck; Dalila B Corry
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 5.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

6.  Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.

Authors:  George Michas; Marcel Liberman; Kristian C Becker; Diane E Handy; Joseph Loscalzo; Jane A Leopold
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

7.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 8.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

Review 9.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

10.  Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.

Authors:  Simmi Dube; Barbara Norby; Vishwanath Pattan; Ravi K Lingineni; Ravinder J Singh; Rickey E Carter; Ananda Basu; Rita Basu
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.